What to do when a care-home resident refuses a medicine

Respect the refusal while checking immediate safety

A resident pushes away a medicine or says they do not want it. The response starts by recognising that the person has expressed a choice. Staff should not relabel the event as a missed dose to avoid a difficult conversation, and they should not hide the medicine in food. The right to refuse is one of the safe administration principles in NICE SC1. CQC's MAR guidance says a person with mental capacity has the right to refuse medicine even when staff or family think the choice unwise.

Check whether there is an immediate safety issue. What medicine was due, why is it prescribed, when was the last confirmed dose and how is the resident now? A care worker should not decide independently that a refusal is harmless or that it creates an emergency. Use the resident's agreed refusal plan if one exists, and seek advice from the prescriber or an appropriate urgent clinical service when the medicine or resident condition makes delay significant. If the resident is acutely unwell, follow the home's emergency process. Record the information the clinician needs and the advice received.

Ask, without pressure, whether the resident will explain the reason. They may feel sick, dislike the taste, struggle to swallow, fear a side effect, not recognise the medicine, wish to sleep or simply choose not to take it. They may not want to explain. A refusal does not automatically mean the resident lacks capacity or that the care worker has failed. Understanding the reason can reveal a practical problem that can be addressed lawfully, but a person is not required to justify a capacitated refusal to staff satisfaction.

Do not force, deceive or repeatedly present the same dose until the person gives in. Record the refusal honestly. Hand over any time-sensitive risk and the next action. If the resident later changes their mind, staff still need medicine-specific advice about whether a late dose is appropriate and how it affects the next scheduled dose. This page provides no catch-up dosing rule.

Check communication before assuming the decision is fixed

The way a medicine is offered can influence the answer. Make sure the resident knows what is being offered in a form they can understand. Use their preferred language, accessible information, hearing or vision support and a calm setting. Avoid a rushed exchange during a busy round. A resident who says “no” because they think a tablet is a different medicine may respond differently when the information is clear. The goal is informed choice, not persuasion at any cost.

Ask what matters to the person. Is the medicine associated with an unpleasant effect? Do they want to know its purpose? Is swallowing difficult? Is the time inconvenient because of meals, sleep or personal care? Does the formulation cause distress? A pharmacist or prescriber may be able to review the timing, formulation or treatment if the resident wants that. Staff must not crush tablets, open capsules, mix medicine into food or change the dose without appropriate advice and authorisation. A seemingly helpful change can alter how a medicine works or hide it from the person.

Check the current care plan for agreed support. The plan may describe how the resident prefers to be approached, whether they self-administer, whether they need help opening packaging or whether a familiar staff member should explain a medicine. An agreed approach should be person-centred and reviewable. It is not authority to ignore a new refusal. The resident's present words and behaviour still matter.

Allow space for the person to consider information. A single refusal during a noisy round may be followed by a later decision, but the timing of any later offer must be clinically safe. Ask a professional before creating a new dose time where the medicine is time-sensitive or the next dose is approaching. Avoid repeatedly offering the medicine as a tactic to wear down the person. Record both the original refusal and any later choice, with the times and advice that governed the action.

Assess capacity for this decision when there is a real reason to doubt it

Capacity is decision-specific and time-specific. A diagnosis, age or care-home residence does not settle whether the person can decide about this medicine now. The Mental Capacity Act 2005 starts from a presumption of capacity, requires support to make a decision and recognises that an unwise choice does not itself show incapacity. If staff have a genuine concern about the person's ability to understand, retain, use or weigh relevant information or communicate a choice, follow the service's capacity assessment process with the appropriate professional and record the basis for concern.

NICE asks practitioners to identify factors that may hinder informed consent, including communication barriers, health problems and mental health difficulties. Check whether the resident can decide with better information, a quieter time, an interpreter or another support. If a person has fluctuating capacity, the timing of the decision may matter. An urgent medicine decision may still require prompt clinical assessment. Do not use “lacks capacity” as a shortcut because the person disagrees with staff.

If the person lacks capacity for this particular decision, an authorised best-interests process is needed. Involve the person as far as possible and consider their wishes, feelings, beliefs and values. Consult those who know the person where appropriate. Identify who has legal authority to make or participate in the decision, including any relevant health and welfare attorney or court order. A relative's strong preference alone does not automatically authorise staff to administer a refused medicine. A clinician should assess treatment options and risks.

Document the decision process and review it when circumstances change. Capacity may return, the medicine may change or the resident may respond differently at another time. A standing statement that “resident lacks capacity for medication” is too broad to answer every future medicine decision. The care team needs a plan it can apply to the actual medicine, decision and circumstances.

Never treat covert administration as the immediate workaround

Hiding medicine in food or drink is covert administration. CQC's covert administration guidance says it should only be considered where a person actively refuses and has been assessed as lacking capacity to understand the consequences of that refusal. The decision must follow Mental Capacity Act principles and a best-interests process. Appropriate pharmaceutical advice is essential because altering a medicine or mixing it with food can change its effect.

A covert plan requires more than a manager's instruction or a family's request. The team needs a documented decision about the medicine, why covert administration is necessary, how it will be given safely, who is involved and how the plan will be reviewed. The prescriber and pharmacist may need to consider alternatives. If the person has capacity to refuse this medicine, covert administration is not justified by the fact that staff believe it is beneficial.

Do not crush a tablet and put it in dessert while the formal process is being arranged. Do not use an old covert plan after a medicine or dose change without review. If the person is at immediate clinical risk because treatment is refused, seek urgent professional advice about the lawful and clinically appropriate response. A care worker should not improvise a hidden dose. The detailed covert decision belongs to a separate cluster owner because it needs a different legal, pharmaceutical and review pathway.

Record the refusal precisely on the MAR and care record

NICE SC1 recommendation 1.2.3 asks care-home staff to record the circumstances and reason for refusal, if the resident gives one, in the care record and MAR unless an agreed refusal plan already covers what to do. CQC guidance says the MAR should record medicines taken and refused. Do not sign a dose as given when it was not taken. Do not leave a blank box that looks like a missed entry. Use the correct refusal code or clear wording according to the home's system.

Record the time, medicine, dose, what the resident said or did, any reason they chose to give, information and support offered, the resident's condition, clinical advice and the follow-up plan. Keep observation distinct from interpretation. “Resident said the tablet makes them feel sick” is more informative than “non-compliant.” If the person gave no reason, record that without inventing one. If the refusal is part of an agreed plan, identify the plan and any action it required.

The care record should explain the decision journey that the MAR cannot hold in a small box. Note whether the resident appeared able to understand the choice, whether communication support was used and whether a capacity assessment was needed. If a professional was contacted, record who, when, the facts shared and advice. If the person later accepts a dose, record the actual administration time and the authorising advice if timing changed. Maintain the audit trail in paper or electronic records.

Share the information at handover. The next shift needs to know whether to offer the next scheduled dose, whether a prescriber is reviewing the plan, what observations are required and whom to contact if the resident's condition changes. “Refused meds” is not a sufficient handover when several medicines have different risks. Use the resident's clinical system as the source for administration and treatment instructions.

Escalate repeated refusal without removing the person's choice

A single refusal and an ongoing pattern can require different responses. If refusals recur, ask whether the treatment remains wanted, appropriate and practical for the resident. The prescriber should know about ongoing refusal so the medicine can be reviewed rather than continuing to prescribe a treatment the person does not take. NICE SC1 says that, with the resident's agreement, staff should tell the prescribing health professional about ongoing refusal and inform the supplying pharmacy to prevent further unnecessary supply. The wording matters: sharing information should follow consent and confidentiality rules.

Bring a clear pattern to the review. Which medicine was refused, on which dates, at what times and in what circumstances? Did the reason change? Was there an effect on the resident's condition? What communication or formulation changes were tried with professional agreement? Did the resident accept another medicine or the same medicine at a different time? A pattern can reveal swallowing difficulty, adverse effects, misunderstanding or a conflict with daily routine. It can also show a stable, informed choice that deserves respect.

Ask the prescriber and pharmacist whether there are suitable options. The answer may be a different formulation, timing, treatment or monitoring plan. It may be a decision to stop a medicine after clinical review. Care staff should not stop, replace or alter a prescription on their own. If the resident wishes to discuss benefits and burdens, support access to the prescribing professional. Document the agreed plan in the care record and MAR, and ensure all shifts use the current version.

Review risk without coercion. Some repeated refusals may raise a safeguarding concern if staff are withholding medicine, pressuring the person or failing to seek help for a serious need. Others are an exercise of a capacitated resident's right. The provider must distinguish these situations on facts. Escalate a genuine safeguarding concern through the local route while protecting the resident. Do not treat every informed refusal as a safeguarding event or every refusal as a staff error.

Explain the situation to family and representatives lawfully

Family members may be worried and may ask staff to make the resident take the medicine. Listen and explain the resident's rights and the clinical review route without disclosing more than the resident has authorised or the law permits. Where the person has capacity, ask whether they want a family member involved. A relative can offer helpful context, such as a long-standing swallowing problem or a previous adverse experience, but cannot erase a capacitated refusal.

Where capacity is lacking, consult relevant people as part of the best-interests process. Check any health and welfare lasting power of attorney or court decision rather than assuming that “next of kin” automatically has legal decision-making power. Record who was consulted and how their information influenced the decision. The resident should still be involved as far as possible. The care plan must state the outcome and review point, not simply that the family agreed.

Be clear about clinical uncertainty. Staff can say that the resident declined a dose, that advice has been sought and what the agreed next step is. They should not promise that a missed dose will cause no harm or that the medicine will be given later. The prescriber can explain medicine-specific consequences and options. If a complaint arises, handle it through the provider's normal process while continuing the resident's care and respecting confidentiality.

Avoid confusing refusal, omission and error reporting

A resident's informed refusal is not automatically a medicines administration error. The service still needs an accurate record, a safe response and escalation where the medicine or situation requires it. An error may occur if staff fail to offer the medicine, misrecord a refusal, ignore a clinical plan or administer against the person's rights. If such an error occurs, use the medicines incident process. CQC's reporting guidance puts the person's safety first and asks providers to learn from medicines incidents.

Do not automatically notify CQC because a resident refused a dose. Statutory notification depends on a qualifying event, such as serious injury, abuse or another reportable incident, and the actual facts. A capacity or best-interests problem may need safeguarding review. Record the reporting decision and rationale. If the service's own actions caused harm or a notifiable safety incident, consider the statutory duty of candour under Regulation 20. General openness with the person is always important.

This boundary matters for search intent. The missed-dose guide addresses a scheduled dose that staff may have failed to give. This guide addresses the resident's expressed choice and the consent, capacity and ongoing-treatment decisions that follow. A future covert-administration page would address a formally authorised best-interests pathway. Folding all three into one generic “medication error” article would hide the most important difference in what the care team must do.

Example: repeated refusal of an evening tablet

A resident declines an evening tablet and says it makes them feel unwell. The worker does not argue or hide it in food. They check the care plan, record the refusal on the MAR and note the resident's own words. They check the resident's condition and follow the agreed route for medicine-specific advice. The next shift receives a clear handover, including whether a clinician has advised on the next scheduled dose. The resident is asked whether they would like a discussion with the prescriber.

The following week, the pattern repeats. The manager reviews the MAR and care notes, confirms that staff have offered information in a way the resident understands and arranges a prescriber and pharmacist review. The resident participates. If the person has capacity for this decision, the team respects their refusal while discussing alternatives and monitoring. If there is a genuine capacity concern, the service follows a decision-specific assessment and best-interests process. No one treats the relative's preference as permission to conceal the medicine.

The updated plan records what the resident wants, what the prescriber decided, what staff should offer, how to respond to another refusal and when to review. The manager checks a later sample of records to see whether every shift follows the plan. This example shows an information and decision process. It does not imply that repeated refusal has one clinical answer.

Where Complys may fit

The live Complys care home guide says Complys does not replace a clinical care system's day-to-day medication record. It discusses policies, staff competence, audits and incident governance. Public material does not verify a MAR, capacity assessment, best-interests decision tool, prescribing function or automatic CQC notification. Product claims about those functions should remain out of published copy unless the product owner confirms them.

An administrative system may support review of the home's medicines policy, staff competence, incident actions and governance evidence if those workflows are available. Keep the resident's choice, clinical advice and administration record in the authorised care system. A manager may need to know that a repeated-refusal plan was reviewed without making the compliance platform a second clinical record. Check access, purpose and retention before copying sensitive details.

CTA: Review Complys for Care and ask which policy, training, incident and audit workflows are currently available alongside the home's clinical records. Related tool opportunity: A refusal-response worksheet that prompts staff to record the person's words, communication support, immediate risk, clinical advice, consent or capacity pathway, MAR entry, ongoing review and handover. It must not decide capacity or authorise covert administration. Suggested internal links out: Missed-dose response, care home CQC guide, the future covert-administration owner if approved. Suggested links in: Care home medicines section, future care medicines cluster page and any approved capacity or covert-administration guide. Cannibalisation boundary: This page owns an expressed refusal of medicine and the consent, capacity and repeated-refusal plan. Draft 70 owns a missed or uncertain scheduled dose. A separate covert owner would cover a formal best-interests decision to administer without the person's knowledge. No pages should be made by medicine name or care-worker title without distinct information gain.